CG MedTech Co (056090.KQ) Stock Price

CG MedTech Co Price

CLOSED
4,105.00
​
Market closed

Revenue has compounded at 10.6% per year over the past 12 years to 47.23 B KRW. Earnings per share have declined at 11.1% per year over the last 12 years. CG MedTech Co's net margin stands at 13.8%, up from -13.1% several years earlier.

CG MedTech Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CG MedTech Co business model & stock analysis

CG MedTech Co Ltd generates revenue through two primary business segments. The Medical Device Business segment produces and sells spinal fixation devices, micro-invasive medical devices for back pain treatment, fracture treatment devices, and bioabsorbable alloy implants. These products are sold to healthcare providers and hospitals within the orthopaedic surgical market. The Electric Energy Business segment manufactures and markets electricity meters and integrated calorimeters, targeting utility companies and energy management sectors. Both segments operate under the company's established brand presence in their respective industries. The company's revenue streams are derived from direct sales to end-users in the medical and energy sectors. Orthopaedic surgical implants and devices are purchased by hospitals and clinics specializing in orthopaedic care, while electricity meters and calorimeters are bought by utility providers for infrastructure deployment. The firm's product portfolio is designed to meet specific technical requirements within these specialized markets. CG MedTech Co Ltd's business model focuses on manufacturing high-precision medical devices and energy measurement equipment. The Medical Device Business segment serves the healthcare industry with products for spinal and fracture treatments, while the Electric Energy Business segment supports energy management through metering solutions. This dual-segment approach allows the company to serve two distinct but complementary industrial sectors.

Frequently asked questions about CG MedTech Co

5 analysts currently rate the CG MedTech Co stock: 4 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the CG MedTech Co share trades at 2.73 EUR (4,105.00 KRW).

The revenue cannot currently be calculated for CG MedTech Co.

The profit cannot currently be calculated for CG MedTech Co.

The P/E ratio cannot be calculated for CG MedTech Co at the moment.

The P/S cannot be calculated for CG MedTech Co currently.

The Eulerpool Quality Score for CG MedTech Co is 4/10.

The ISIN of CG MedTech Co is KR7056090004. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of CG MedTech Co is 056090.KQ. The ticker symbol is used to trade CG MedTech Co shares on the stock exchange.

Fair ValueTerminal
3,899.75 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website inno-sys.net
Country
South Korea
Currency
KRW
Initial public offering
Nov 12, 2015
ISIN
KR7056090004
Cusip
Y9T346109
Market capitalization
385.21 B KRWMega Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
98.43
P/B Ratio
4.10
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
6.86 %
Last updated Nov 11, 2026, 12:43 PM

CG MedTech Co Peer Group

CG MedTech Co FIGI

056090:KS · BBG0032N7FY2056090:KQ · BBG00B52FD19

All fundamentals and in-depth analysis of CG MedTech Co

Our stock analysis for CG MedTech Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CG MedTech Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.